Regulators around the world are getting tough on drug-makers amid soaring prices that companies say are justified by years of research and product development.
Chukwuma Muanya Assistant Editor
Advertisement
The News You Need, Delivered To You.
Subscribe to the Guardian today and never miss the stories that shape your Business
Follow Us on Google News
